Every cell and gene therapy has its complexity and unique program. To get your therapy to market, rely on the leading cell and gene therapy manufacturer with an excellent team and high-tech facilities.
At Novartis, various kinds of cells can be analyzed, studied and activated using different viral vectors and related ex-vivo processes.
Our services include manufacturing at clinical and commercial scale. Therefore, state-of-the-art equipment for cell processing and expansion is installed and ready to be used. Cryopreservation of patient or donor cells and final products is available. Specific analytical capabilities are included in our services.
The supply chain management setup ensures a best-in-class cell line identity.